別包装 |
あり
|
純度 |
>=97%, TLC, HPLC
|
分子量 |
805.05
|
CAS RN® |
11050-94-5
|
化合物の概要 |
Macrolide; F1F0 ATP synthase inhibitor.
|
構造 |
C45H72O12
|
溶媒 |
Soluble in DMSO, ethanol, acetone.
|
使用目的 |
Oligomycin B is a macrolide antibiotic initially produced by several species of Streptomyces. Oligomycin B inhibits mitochondrial F1F0 ATP synthase, binding the F0 subunit, inhibiting ATP synthesis; it displays antibacterial efficacy against a variety of bacteria. In myocardial tissue, oligomycin B decreases ATP concentrations and contractile function under normoxic conditions, but instead decreases the ATP depletion rate during ischemic or hypoxic conditions. When administered in large doses, oligomycin B causes hypertension, bradycardia, increased arterial PO2, and metabolic acidosis. Oligomycin B inhibits mitochondrial function and is often used to mimic hypoxia-induced conditions.
|
その他 |
[融点]156 - 164 ℃ [外観]White powder
|
参考文献 |
Grover GJ, Malm J. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Cardiovasc Ther. 2008 Winter;26(4):287-96. PMID: 19035880.Grover GJ, Atwal KS, Sleph PG, et al. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1747-55. Erratum in: Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H484. PMID: 15371268.Koos BJ, Sameshima H, Power GG. Fetal breathing movement, sleep state and cardiovascular responses to an inhibitor of mitochondrial ATPase in sheep. J Dev Physiol. 1986 Feb;8(1):67-75. PMID: 2937831.
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
LKT
|
O4532
|
5 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
4℃
|
|